Gilead Sciences Inc
NASDAQ: GILD
$83.94
+$0.04 (+0.0%)
Closing Price on September 20, 2024
GILD Articles
ThinkstockA brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are trial data, FDA decisions and company presentations coming soon. The...
Published:
An new report from Credit Suisse highlights the stocks where large-cap fund managers have been placing new bets the most. We screened those stocks for ones rated Outperform at Credit Suisse.
Published:
bfishshadow via Wikimedia CommonsShort sellers shied away from four of the top five most shorted stocks on the Nasdaq between the June 30 and July 15 settlement dates. The outlier was Frontier...
Published:
ThinkstockGilead Sciences Inc. (NASDAQ: GILD) has now reported its second-quarter earnings. The largest biotech by market cap turned in earnings of $2.36 per share ($3.93 billion) on more than a 100%...
Published:
ThinkstockEarnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will change...
Published:
In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current earnings expectations. But 24/7 Wall St. has one caveat.
Published:
courtesy of Sirius XM RadioHere is a look at the seven Nasdaq-traded stocks with the largest number of shares held short as of June 30. Six of the seven experienced declines in short interest, and...
Published:
Last Updated:
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit the tape.
Published:
A surge in short interest in Apple shares between the May 30 and June 13 settlement dates was enough to lift the tech giant into the top five most shorted stocks on the Nasdaq.
Published:
bfishshadow via Wikimedia CommonsShort sellers continue to hold huge positions in the same handful of Nasdaq stocks, but among them, short interest in Sirius, the Nasdaq-traded stock with the largest...
Published:
ThinkstockShort sellers have many reasons to bet against a stock, some of which are hedging or part of a larger theme. Other reasons may be a bet against a company or sector, or in the case of...
Published:
A new research note from Credit Suisse maintains that the top large cap biotech leaders are leading the comeback rally from the hard sell-off. Here are the top large cap biotech stocks to buy at...
Published:
Last Updated:
ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The...
Published:
bfishshadow via Wikimedia CommonsHere is a look at the seven Nasdaq-traded stocks with the largest number of shares held short as of May 15. Six of the seven experienced declines in short interest,...
Published:
Last Updated:
ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance at the American Society of Clinical Oncology yearly conference. Many of...
Published: